Afuco™ Anti-Human ITGA1 ADCC Therapeutic Antibody (SAN-300), ADCC Enhanced
Anti-ITGA1 ADCC Enhanced Antibody (SAN-300) is an ADCC enhanced antibody produced by our Afuco™ platform. SAN-300 is an investigational humanized anti-VLA-1 monoclonal antibody and an inhibitor of VLA-1, also known as α1β1 integrin. SAN-300 has potential application in multiple inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, psoriasis, asthma and organ transplantation.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-435CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | ITGA1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |